Meconeuron Injection contains Methylcobalamin 500 mcg, an active form of vitamin B12 essential for neurological function and hematopoiesis. It is indicated for the treatment of vitamin B12 deficiency, which may present as peripheral neuropathy, megaloblastic anemia, or other neurological disorders. Methylcobalamin plays a critical role in DNA synthesis, nerve cell repair, and myelin sheath formation, thereby aiding in the restoration of nerve function and the prevention of irreversible neurological damage. Meconeuron Injection is administered intramuscularly or intravenously, ensuring rapid bioavailability and effective correction of deficiency states. It is particularly beneficial in conditions such as diabetic neuropathy, alcoholic neuropathy, and other neurodegenerative disorders where vitamin B12 metabolism is impaired. The injection is also useful in patients with malabsorption syndromes, pernicious anemia, or those undergoing prolonged treatment with medications that interfere with vitamin B12 absorption. Adverse effects are rare but may include mild injection site reactions or allergic responses. Meconeuron Injection should be used under medical supervision, with dosage and duration tailored to the individual patient’s clinical condition and response to therapy. Regular monitoring of vitamin B12 levels and neurological status is recommended to optimize therapeutic outcomes.